Xstrahl has just returned from the 64th Annual Meeting of the Radiation Research Society in Chicago, which as usual featured some of the best of recent technology, papers and experts.
We would like to thank everyone who came to our booth to see Xstrahl’s latest innovations, to discuss radiation research trends, hypotheses or to speak with one of our own radiotherapists. Hours of demonstrations and talks, and hundreds of questions asked and answered, made these four days unforgettable. This genuine interest and commitment to enhance preclinical research capabilities fuel our passion for constant innovation and development to be able to offer you the best in class solutions you deserve.
We also would like to mention the success of our scientific officer, Amanda Tulk who presented her poster “Dosimetry considerations in preclinical radiobiology and small animal radiotherapy” co-authored with University of Hull and Innovate UK. And we are delighted to share that our state-of-the-art image-guided small animal radiation platform SARRP had been used to write 15 presentations and abstracts at RADRES.
“RADRES has always been a favourite in our events calendar, bringing together a plethora of experts, who share our aim to constantly push the profession to achieve innovative solutions. It is an honour to be your trusted partner and to be able to provide the best and most advanced technologies and innovations for all of your research needs,” said Adrian Treverton, CEO of the Xstrahl Group. “The new imaging accessory, MuriFocus and our enhanced 3D imaging platform, Muriglo, were presented this year and very well received by the research community. We are leaving Chicago sure that the technology we bring to radiotherapy can help ensure the best research possible. Eat, Sleep, Radiate, Repeat”.
